Company news
Ventripoint Diagnostics Ltd. (TSXV:VPT) news
Ventripoint Diagnostics Ltd. news releases on 6ix. Latest, Aug 9, 2021: Ventripoint Announces Patent Application for Improved Heart Analysis
Press releases — page 5
Ventripoint Announces Patent Application for Improved Heart Analysis
August 9, 2021
Ventripoint Engages Digital257 for Social Media and Investor Relations Services
July 5, 2021
Ventripoint Issues Option Grants to Consultants and a Director of the Corporation
July 2, 2021
Ventripoint Announces Sponsorship for the 54th Annual Meeting of the Association of European Paediatric and Congenital Cardiology
May 21, 2021
Ventripoint update on its Financial Status and on Warrant and Option Exercises
May 6, 2021
Ventripoint Receives Government Funding to Advance Development of Next Generation of VMS+
May 4, 2021
Ventripoint Collaborates with GE Healthcare to Bring More Functionality to its Cardiac Ultrasound Devices
April 27, 2021
Ventripoint Attends 23rd Annual Canadian Echo Weekend and Grants Stock Options
April 20, 2021
Ventripoint Extends Patent Portfolio with Foundational U.S. Provisional Patent Filing of Heart Motion Tracking Technology
April 19, 2021
Ventripoint Announces Sponsorship for the 2021 Canadian Society of Echocardiography Weekend Conference
April 15, 2021
Ventripoint Diagnostics Begins Publication of Case Studies Showing Meritorious Use of the VMS Heart Analysis System
April 13, 2021
Ventripoint JV Begins Process to have Heart Analysis System Certified for use in COVID Patients in China
March 16, 2021
Ventripoint Passes Regulatory Inspection of Manufacturing Facility and Audit of Quality Assurance System
March 9, 2021
Ventripoint Announces Extension Warrants from March 23, 2021 to May 23, 2021
March 3, 2021
Ventripoint Diagnostics Receives Additional Innovation Assistance Program Funding and Updates Warrant Exercises
March 3, 2021
Ventripoint JV Begins Training Chinese Cardiologists in Heart Analysis System and Achieves Milestone of First Commercial Sales
March 2, 2021
Correction - Ventripoint Diagnostics Issues Shares in Final Payment of Debenture Interest
February 24, 2021
Ventripoint Heart Analysis System to be used at the Stollery Children's Hospital to Study Atrial Dysfunction in Children
February 23, 2021
Ventripoint Advances Sales, Marketing, and Distribution Partnership in the Largest Market in World for Heart Disease: China
February 16, 2021
Ventripoint Diagnostics Issues Shares in Final Payment of Debenture Interest
February 10, 2021
Ventripoint Diagnostics Upgrades Investor Relations Webpage
February 9, 2021
Ventripoint Issues Option Grants
February 8, 2021
Correction: Ventripoint Accelerated Expiry Date of Warrants
February 8, 2021
Ventripoint Hires MarketSmart Communications to Provide Investor Relations Services
February 5, 2021
Ventripoint Announces Complete Conversion of Secured Convertible Debentures, Exercise of Warrants and Accelerated Expiry Date of Warrants
February 3, 2021
Ventripoint Issues Option Grants and Exercises
January 27, 2021
Ventripoint Diagnostics Issues Shares in Payment of Consulting Fees
January 18, 2021
Ventripoint Announces Filing of Articles of Amendment
January 13, 2021
Ventripoint Expands to Address the Needs of Companion Animals
January 11, 2021
Kings College London Receives VMS+3.0 Ventripoint Whole Heart Analysis System
January 4, 2021
Ventripoint Diagnostics Receives Loan from FedDev Regional Relief and Recovery Fund and Reminds Shareholders about Annual General Meeting Today
December 14, 2020
Ventripoint Diagnostics Receives Wage Subsidy
December 10, 2020
Ventripoint Diagnostics Issues Shares in Payment of Debenture Interest, Consulting Fees and DSU Exercise
November 26, 2020
Canada's Largest Cardiac Centre Receives VMS+3.0 Ventripoint Whole Heart Analysis System
November 5, 2020
Ventripoint Engages Oak Hill Financial to Provide Investor Relations Services and Approval of Warrant Amendment
November 3, 2020
Ventripoint Makes Application to Amend Warrrants
October 9, 2020
Ventripoint Installs Whole Heart Analysis System in MD Anderson Cancer Center in Houston
October 8, 2020
Ventripoint Announces Appointment to the Board of Directors and Option Grants
September 30, 2020
Ventripoint Remotely Installs Whole Heart Analysis System in Major European Hospital
September 28, 2020
Correction: Options at exercise price of $0.10. Ventripoint Engages Torrey Hills Capital to Provide Investor Relations Services
September 25, 2020
Ventripoint Engages Torrey Hills Capital to Provide Investor Relations Services
September 25, 2020
Ventripoint To Resume Trading at the Market Opening Friday, September 25, 2020
September 23, 2020
Ventripoint Provides Corporate Update and Enters Review by TSXV to Resume Trading
September 15, 2020
Ventripoint Announces Closing of Second Tranche of Non-Brokered Secured Convertible Debenture Unit Private Placement
September 14, 2020
Ventripoint Announces Postponement of First Quarter Filings
May 29, 2020
Ventripoint Announces Closing of First Tranche of Non-Brokered Secured Convertible Debenture Unit Private Placement and Exchange of Existing Debentures and Repricing and Extension of the Associated Warrants
February 10, 2020
Ventripoint Provides Corporate Update and Announces $1,220,000 Non-Brokered Debenture Unit Private Placement and Exchange of Existing Debentures and Repricing and Extension of the Associated Warrants
January 28, 2020
Ventripoint Clarifies News Release of December 17, 2019
December 19, 2019
Ventripoint Diagnostics Provides Corporate Update
December 18, 2019
Ventripoint Diagnostics to Exhibit at Radiological Society of North America's 105th Scientific Assembly and Annual Meeting
November 29, 2019